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Siunmary: An HPLC-based method for the determination of creatinine was evaluated, with emphasis on
interference by bilirubin.
The method differed from other procedures, in that deproteinization was by Ultrafiltration instead of
precipitation with trichloroacetic acid. This allows a rapid, direct analysis by HPLC with very few experimental
Steps.
Analytical results showed linearity up to 5000 μιηρί/ΐ and an average analytical recovery of 100%.
Within-day imprecision was 0.8 — 1.4%, and day-to-day imprecision was 0.5—2.4%.
Introduction
It has been known for years that the routine deter-
mination of creatinine in serum can present labora-
tory workers with serious problems.
The traditipnally used methods are all based on the
well known Jaffe reaction (1). In spite of the many
modifications of this method, interference by one or
m re s bstances still exists. A comprehensive list is
given by Young et aL (2).
We met this problem in pur laboratory after the
introduction of the Technicon Chem l analyser. Cli-
nicians criticized the value of some creatinine results,
and mpst of the speciineiis in question turned out to
be icteric. Bilirubin, the m st troublesome interferent
in the creatinine determination, is elevated (> 20
μιηοΐ/ΐ) in about 16% of our daily worklpad. It there-
fpre appeared expedient to study the state of the art
of the Chem l analyser with respect to interference
by bilirubin with the creatinine determination. We
have already drawn attention to this interference in a
previous publieation (3).
It was clear that in order to answer this question a
reliable method was needed. From the literature it is
known that high-performance liquid chromatography
(HPLC) can be suitable analytical method.
High-performance liquid chromatography for the de-
termination of creatinine in serum has been described,
using both reversed-phase (5 — 8) and ion exchange
Systems (9-12).
However, almost all techniques described have a low
throughput, either due to long column precondition-
ing or to gradient elution.
Furthermore the use of trichloroacetic acid, used in
a number of techniques s a deproteinizing agent, is
not free of risks. The risks are inclusion of creatinine
and conversion of creatine to creatinine (4).
We therefore considered Ultrafiltration s an inde-
pendent mearis pf deproteinization (13). Deproteini-
zation of serum by Ultrafiltration and subsequent
direct analysis of the aqueous supernatant could offer
a true advantage over the established methods that
use trichloroacetic acid.
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Materials and Methods
Materials
Reagenls
All Chemicals vvere at least reagent grade. Creatinine (> 99%),
bilirubin, trichloroacetic acid (20%), acetic acid (100%), hy-
drochloric acid (37%), dimethylsulphoxide, sodium carbonate,
methanol Lichrosolv and acetic acid, were obtained from
Merck, Darmstadt, Germany. The concentration of trichloro^
acetic acid used was 0.6 mol/1 (10%).
Lithium acetate dihydrate, MicroSelect, was obtained from
Fluka BioChemika AG Buchs, Switzerland.
Creatinine iminohydrolase (EC 3.5.4.21) used for interference
studies was obtained from Sigma, St Louis, MO, U. S. A.
Water was purified with the Milli-Q water System from Milli-
pore, Molsheim, France.
A stock solution of 10 mmol/1 creatinine was prepared in 20
mmol/1 hydrochloric acid and was used to make seven aqueous
Standard Solutions covering the r nge 50—1000 μιηοΐ/ΐ.
The serum samples were stored for up to one month at — 80 °C
until further use.
Standard reference material 909 from the National Institute of
Standards and Technology, U. S. A. was used together with two
levels (Kontrollogen-L and -LP) control sera from Behring-
werke A. G., Marburg, Germany, to evaluate the HPLC
method.
Furthermore, six reference sera (A, B, C, D, E, F) from the
Deutsche Gesellschaft f r Klinische Chemie*, Zentrale Referenz-
institution were used s control material. In all sera the creat-
inine determination was performed by isotope dilution-mass
spectrometry and by a validated reference method.
Methods
Ultrafiltration
The disposable Centrifree Micropartition System from Amicon
used in a fixed-angle rotor (JA-21 Beckman) provides an ul-
trafiltrate which is almost free from protein after centrifugation
at 1000#.
In the removal of protein from a serum sample by ultrafiltra-
tion, there is a decrease of the total sample volume due to the
removal of proteins.
A factor of 0.9456 is used to adjust for this change in volume
according to Weast (15).
Sample preparation
A serum sample (100-300 μΐ) was centrifuged for 20 minutes
and ΙΟμΙ ultrafiltrate was directly injected into the HPLC
System.
Blank sample preparation
Serum (500 μΐ) was mixed with 50 μΐ Tris buffer containing 20
kU/1 creatinine iminohydrolase and incubated in a closed tube
for 60 minutes at 37 °C.
Bilirubin interference
The protocol worked out by the Societe Fran^aise de Biologie
Clinique was used to study interference by bilirubin (14).
High performance liquid chromatography (HPLC)
The HPLC System from Spectra Physics consisted of a SP8800
HPLC pump, a SP8780 autosarnpler, a SP8790 column heater,
a SP8450 UV detector and a SP4290 integrator. The HPLC
procedure is essentially according to Kagedal & Olsson (l 1).
The weak cation-exchange column was a 150 χ 4.6 mm I.D.
column froni Βίο-Rad, Richmond, CA, U. S. A., urinary me-
tanephrine kit, Cat. No. 195-6001.
The elution buffer was lithium acetate 15 mmol/1. The pH was
adjusted to 4.80 with acetic acid and filtered (0.45 μήι celiulose
acetate/nitrate membrane, Millipore, Molsheim, France) foefore
use. The eluent was a mixture of lithium acetate — methanol
(95 -l· 5 by vol.), and the flow rate was 1.0 ml/min.
Beca se there was no dilution of the sample with trichloroacetic
acid s in the original procedure, we preferred to reduce the
injection volume from 20 to 10 μΐ in order to minimize peak
broadening. The column teinperature was raised to 40 °C, in
order to diminish peak tailing. The absorbance was monitored
at 234 nm, and calibration was performed with aqueous external
Standards.
Results
Preliminary experiments, performed exactly according
to the procedure of Kagedal & Olssen with aqueous
Standard material, occasionally showed a second peak
or tailing peaks. We suspected trichloroacetic acid,
because reductipn of the amount of trichloroacetic
acid more or less solved this problem. We decided to
study this phenomenon at a later stage and to circum-
vent the problem by applying the Amicon Centrifree
Micropartition System, because this System had
worked very well in initial experiments. This System
provides aii almost protein- and bilirubin-free ultra-
filtrate and requires only 100 μΐ of serum.
Because of this modificatiori we had to re-examine
the precision, accuracy, linearity, sensitivity and re-
covery of the method.
Precision
Analytical imprecision was calculated from two com-
mercially available human control sera with creatiniiie
levels of 123.5 μπιοΐ/ΐ (Kontrollogen L) and 293
μηιοΐ/ΐ (Kontrollogen LP). Within-day imprecision
was determined by six replicate analyses of Kontrol-
logen L and LP.
Between day imprecision was assessed using the same
controls, divided into aliqu ts and stored at —20 °C.
On 10 separate occasions an aliquot of each level was
thawed and analysed. The results are shpwn in t ble l.
Accuracy
To evaluate the accuracy of the HPLC method, we
analysed seven sera, the creatinine values of which
o had been determined by isotope dilutions-mass spec-
trometry or by a reference mettyod (see tab. 2).
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Tab. 1. Within- and betwccn-day imprecision of creatinine
measurcments.
Within-day
(n = 6)
Between-day
(n = 10)
Mean
μraol/l)
121
296
121
293
SD
(μπιοΐ/ΐ)
1.7
2.2
1.9
3.7
CV
(%)
1.4
0.8
1.6
1.3
Tab. 2. Accuracy of creatinine measurements by HPLC.
Pool Refer- Meanb SD CV Re-
ence cov-
value* ery°
(μιηοΐ/l) (μπιοΐ/ΐ) (μτηοΐ/ΐ) (%) (%)
A
B
C
D
E
F
538
155
221
109
593
120
544.1
161.0
218.2
110.1
607.0
121.1
12.8
2.5
4.1
2.6
12.0
1.2
2.4
1.6
1.9
2.4
2.0
1.0
101.1
103.9
98.7
101.0
102.4
100.9
SRM 909 151.3
Kontrollogen L 123.5
Kontrollogen 293.0
LP
151.2
120.8
297.9
0.8
0.9
2.9
0.5 99.9
0.7
1.0
97.8
101.6
a
 Values determined by the reference method used by the
'Deutsche Gesellschaft f r Klinische Chemie', except for
S. R. M. 909.
b
 mean values are calculated from n = 4 except for Kontrol-
logen L and LP, where n = 10.
c
 Percent of the reference value.
For all sera the mean concentration of creatinine
measured by HPLC was within 97.8% to 103.9% of
the stated value.
Linearity
We used a calibration curve prepared from aqueous
creatinine Standards covering the r nge 0 — 1000
μιηοΐ/ΐ creatinine. A representative calibration curve
is shown in figure 1. The method proved to be linear
up to 5000 μιηοΐ/ΐ, using an extended calibration set
of 1500, 2000, 3000, 5000 μπιοΐ/ΐ.
Sensitivity
The sensitivity in terms of the differentiation of a
peak from background noise was estimated to be 0.25
μπιοΐ/ΐ (three times the noise).
Recovery
Recovery of creatinine frpm the ultrafiltration System
was checked by means of three aqueous creatinine
3-
ι
100 300 500 700
Creatinine [jjmol/lj
900
Fig. 1. Calibration curve prepared from aqueous creatinine
Standards; all points represent the mean of triplicate
injections. y = 4398x + 700, Sx = 0.8, Sy = 700,
n = 18, r2 = 0.999999.
Standards (125, 500 and 1000 μπιοΐ/ΐ). Furthermore
we added an aqueous creatinine Standard (100 μηιοΐ/ΐ)
to ten serum samples with different creatinine con-
centrations and the same Standard to ten serum sam-
ples with a creatinine level of about 90 μηιοΐ/ΐ (see
tab. 3).
To be absolutely sure that the ultrafiltrate represents
the true creatinine concentration of the sample, we
also used the standard-addition technique to estimate
the creatinine concentration of the two calibrators,
Kontrollogen L and Kontrollogen LP, and the
S. R. M. 909 of the National Institute of Standards
and Technology.
Creatinine was added to a serum sample at a concen-
tration of zero, once and twice the estimated creati-
nine concentration, Four HPLC analyses were per-
formed on each sample.
The average area of these four analyses was used to
calculate the linear regression line through these three
points. The recovery of the additions was found to
be 99.8% ± 0.5%.
The results are shown in table 4.
Interference by bilirubin
Conjugated and unconjugated bilirubin were investi-
gated separately s possible sources of interference.
The conjugated samples were taken from our daily
workload, by measuring the total bilirubin level s
well s the conjugated fraction with the Technicon
Chemrl. The selected samples had a total bilirubin
concentration of > 100 μιηοΐ/ΐ, r nge 102 — 564
μιηοΐ/ΐ, mean 210 μιηοΐ/ΐ, the conjugated fraction
being elevated, r nge 10—279 μιηοΐ/ΐ, mean 117
μηιοΙ/1.
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 29,1991 / No. 12
798 Zwang and Blijenberg: Selected method for creatinine
Tab. 3. Analytical recovery of creatinine after
a) aqueous Standards;
Ultrafiltration.
b) 10 serum samples with a creatinine content of ap-
a.
b.
1
2
2
4
5
6
7
8
9
10
(n
c.
11
12
13
14
15
16
17
18
19
20
n
proximately 90 μπιοΐ/ΐ;
c) 10 serum samples with a creatinine
from 65 to 305 μτηοΐ/ΐ.
Creatinine
added found
(μηιοΙ/1) (μηιοΐ/ΐ)
Aqueous Standards
120 119.3
500 497.5
1000 1000.9
Serum, low creatinine
81
100 183
89
100 188
99
100 198
93
100 193
85
. 100 185
" - 83
100 185
82
100 183
72
100 173
75
100 175
71
100 170
= 10)
Serum, high creatinine
65
100 165
167
100 268
342
100 442
375
100 474
172
100 273
137
100 237
249
201
100 300
166
100 264
305
100 405
= 10)
content ranging
recovery
(%)
99.4
99.5
100.1
102
99
99
100
100
102
101
101
100
99
χ = 100.3%
100
101
100
99
101
100
Λ f\f\100
99
98
100
χ = 99.8%
Tab. 4. Estimatiori of the creatinine concentration in triplicate
of Kontrollogen L and LP, and S. R. M. 909 with Stand-
ard addition to eiiminate volume changes due to filtra-
tion.
Pool Reference Run 1 Run 2 Run 3
value8 (μηιοΐ/l) (μηιοΐ/ΐ) (μπιοΐ/l)
(μιηοΐ/l)
.· t
SRM909 151.3 151.1 151.6 152.4
Kontrollogen L 123.5 120.7 120.2 118.8
Kontrollogen LP 293.0 298.7 299.5 292.9
a
 Values determined by the reference method used by the
'Deutsche Gesellschaft f r Klinische Chemie', except for
S. R. M. 909.
serum was incubated with creatinine iininohydf olase,
and an ultr filtrate was also analysed with the HPLC.
In npne of 100 samples did we find interfering peaks
due to bilirubin or othef s bstaiices. An example is
given in figure 2, a serum sample with a total bilirubin
concentration of 385 μηιοΐ/ΐ.
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Fig. 2. Chromatogram of a serum sample with an elevated
bilirubin concentration of 385 μιηοΐ/ΐ and a creatinine
concentration of 85 μιηοΐ/ before ( ) and after (b) treat-
ment with creatinine iminohydrolase; the peak at 5.80
minutes is creatinine, attenuation is 32 (25). 1000 mV =
Άιΐΐ er»alA
Conjugated bilirubin
We analysed approximately 100 samples with the
HPLC method and with the Chem l analyser, each
sample being analysed twice. First an ultrafiltrate
from the native serum was used to measure the cre-
atinine concentration, next an aliquot of the same
Non-conjugated bilirubin
We investigated bilirubin added t serum, and added
to an albumin/creatinine mixture, according to the
CERMAB protocol (14). The creatinine concentra-
iions in serum were 78, 179 and 269 μιηοΐ/ΐ and in
the albumin solution 89, 223 and 445 μιηοΐ/ΐ. The
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bilirubin concentrations 7, 30, 60, 110, 250, 360, 420
μπιοΐ/ΐ in all dilutions.
The results revealed no interference from unconju-
gated bilirubin, s shown in figure 3.
Apart from these samples, we studied samples from
neonates. These samples (n = 15) were incubated with
creatinine iminohydrolase. Again we found no inter-
fering peak in any chromatogram.
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Fig. 3. The interferogram of bilirubin. Serum samples (creati-
nine 78 (Δ), 179 (x) and 269 (V) μπιοΐ/l) and albumin
samples (creatinine 89 (B), 223 (|) and 445 (f) μιηοΐ/ΐ)
did not show any interference.
Discussion
In his review of the estimation of creatinine (16)
Spencer mentioned the importance of the effect of
bilirubin in kinetic Jaffe procedures. Furthermore, he
said that HPLC methods are relatively quick for single
estimations and that the between-day precision could
be compared to most Jaffe procedures.
The weak cation exchange procedure of Kagedal &
Olssen (11), has introduced a new era of creatinine
estimations. Interference studies showed no interfer-
ence by uric acid, caffeine, xanthine and several drugs,
but bilirubiii was not investigated. Because of the
importance of creatinine concentration s a clinical
Parameter and because of the negative interference of
elev ted bilirubin concentrations we wondered
whether the HPLC procedure could serve s an alter-
native for our routine method in emergency cases.
However, the use of trichloroacetic acid also possibly
causes interference, so we circumvented this problem
by using an ultrafiltration step. A second advantage
of the replacement of trichloroacetic acid by the Ami-
con ultrafiltration System is the elimination of all
dilution Steps, and in our opinion this is the reason
that our precision and recovery are somewhat better
than reported by Kagedal & Olsson. Accuracy also
proved to be good. Retention times for creatinine
were reprodudble and unaffected by creatinine con-
centration and injection volume.
Treatment with creatinine iminohydrolase proved that
the peak with a retention time of 5.80 minutes was
solely due to the presence of creatinine.
Elev ted bilirubin levels did not once show interfer-
ence with any sample after treatment with creatinine
iminohydrolase.
Furthermore, co-elution of an interfering substance
was not observed in any of the examined "normal"
samples used in the initial experiments.
In conclusion, the use of HPLC in combination with
a weak cation exchanger to determine creatinine in
serum is in our view a very fast, easy to use and
accurate back-up System for patient sera with elev ted
bilirubin leVels. In general we feel that our method
meets the Standard of a candidate reference method.
We prefer the use of the Standard addition technique
instead of applying a protein correlation factor. At
the moment we are comparing both modifications,
together with a determination of the water content
(17).
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